The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 7,201–7,300 of 31,469
Lindgren, K., Hagelin, E., Hansén, N., & Lind, L. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000198024.91976.c2 · Cited by 50
Pan, X., Lü, T., Wu, F., Jin, L., Zhang, Y., Shi, L., Li, X., & Lin, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094478 · Cited by 50
Obesity and obesity related co‐morbidities in a referral population of children with asthma
Ross, K. R., Hart, M. A., Storfer‐Isser, A., Kibler, A. M., Johnson, N. L., ROSEN, C. L., Kercsmar, C. M., & Redline, S. S. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21065 · Cited by 50
Krog-Mikkelsen, I., Sloth, B., Dimitrov, D. V., Tetens, I., Björck, I., Flint, A., Holst, J. J., Astrup, A. V., Elmståhl, H. L., & Raben, A. (2011) · Journal of Nutrition · doi:10.3945/jn.110.134627 · Cited by 55
Effect of lifestyle intervention on cardiometabolic risk factors: results of the POWER-UP trial
Vetter, M., Wadden, T. A., Chittams, J. L., Diewald, L. K., Panigrahi, E., Volger, S., Sarwer, D. B., & Moore, R. H. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.92 · Cited by 52
Itou, M., Kawaguchi, T., Taniguchi, E., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05183.x · Cited by 50
Zheng, T., Gao, Y., Baskota, A., Chen, T., Ran, X., & Tian, H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1480 · Cited by 50
Association between serum vaspin concentrations and visceral adipose tissue in Korean subjects
Chang, H. M., Park, H. S., Park, C., Song, Y. S., & Jang, Y. J. (2010) · Metabolism · doi:10.1016/j.metabol.2009.11.021 · Cited by 50
LXR is a negative regulator of glucose uptake in human adipocytes
Pettersson, A., Stenson, B. M., Lorente‐Cebrián, S., Andersson, D. P., Mejhert, N., Krätzel, J., Åström, G., Dahlman, I. A., Chibalin, A., Arner, P., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2954-5 · Cited by 50
Li, K., Li, L., Yang, M., Liu, H., Liu, D., Yang, H., Boden, G. H., & Yang, G. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1023 · Cited by 50
Maternal insulin sensitivity is associated with oral glucose-induced changes in fetal brain activity
Linder, K., Schleger, F., Ketterer, C., Fritsche, L., Kiefer‐Schmidt, I., Hennige, A. M., Häring, H., Preissl, H. T., & Fritsche, A. (2014) · Diabetologia · doi:10.1007/s00125-014-3217-9 · Cited by 51
Insulin resistance and body composition in preterm born children during prepubertal ages
Darendelıler, F., Baş, F., Bundak, R., Çoban, A. Ç., Sancaklı, Ö., Eryılmaz, S. K., Küçükemre, B., Dişçi, R., Gokcay, G., Akı, S., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03119.x · Cited by 50
Johansson, L., Roos, M. W., Kullberg, J., Weis, J., Ahlström, H. K., Sundbom, M., Engström, B. E., & Karlsson, F. A. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9484-0 · Cited by 50
Rojas-Rodríguez, J., Escobar-Linares, L. E., García‐Carrasco, M., Escarcega, R. O., Fuentes-Alexandro, S. A., & Zamora-Ustaran, A. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.01.075 · Cited by 51
Sáinź, N., Rodrı́guez, A., Catalán, V., Becerril, S., Ramírez, B., Gómez‐Ambrosi, J., & Frühbeck, G. (2010) · Mediators of Inflammation · doi:10.1155/2010/784343 · Cited by 51
Serum 25-hydroxyvitamin D (25-OH-D) in obese adolescents.
Garanty‐Bogacka, B., Syrenicz, M., Goral, J., Krupa, B., Syrenicz, J., Walczak, M., & Syrenicz, A. (2011) · PubMed · Cited by 50
Bakkum, A. J. T., Paulson, T. A. W., BISHOP, N. C., Goosey-Tolfrey, V. L., Stolwijk-Swüste, J. M., van Kuppevelt, D., de Groot, S., & Janssen, T. W. J. (2015) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-1946 · Cited by 50
Early Appearance of the Metabolic Syndrome in Socially Reared Bonnet Macaques
Kaufman, D., Smith, E. L., Gohil, B. C., Banerji, M., Coplan, J. D., Kral, J. G., & Rosenblum, L. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0452 · Cited by 50
Ryan, J. M., Crowley, V., Hensey, O. J., McGahey, A., & Gormley, J. (2014) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2014.03.029 · Cited by 50
for the ERA JUMP Study Group, Ahuja, V., Kadowaki, T., Evans, R. G., Kadota, A., Okamura, T., Khoudary, S. R. E., Fujiyoshi, A., Barinas‐Mitchell, E., Hisamatsu, T., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3414-6 · Cited by 51
Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic Inflammation
Walenbergh, S. M. A., Houben, T., Hendrikx, T., Jeurissen, M. L. J., van Gorp, P. J., Vreugdenhil, A. C. E., Adriaanse, M. P. M., Buurman, W. A., Hofker, M. H., Mosca, A., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.29 · Cited by 51
Suliman, A. M., Freaney, R., Smith, T. P., McBrinn, Y., Murray, B., & McKenna, T. J. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01860.x · Cited by 47
Lorenzo, C., Haffner, S. M., Stančáková, A., Kuusisto, J., & Laakso, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2299 · Cited by 50
Aldhoon-Hainerová, I., Zamrazilová, H., Dušátková, L., Sedláčková, B., Hlavatý, P., Hill, M., Hampl, R., Kunešová, M., & Hainer, V. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-100 · Cited by 50
Villarreal‐Pérez, J. Z., Villarreal, J. Z., Lavalle-Gonzalez, F. J., Torres-Sepúlveda, M. D. R., Ruiz‐Herrera, C., Cerda-Flores, R. M., Castillo-García, E. R., Rodriguez-Sanchez, I. P., & Villarreal, L. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-129 · Cited by 51
Hutchison, A. T., Feinle‐Bisset, C., Fitzgerald, P. C. E., Standfield, S., Horowitz, M., Clifton, P. M., & Luscombe‐Marsh, N. D. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.114538 · Cited by 50
Arora, T., Chen, M. Z., Cooper, A. R., Andrews, R. C., & Taheri, S. (2016) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5792 · Cited by 53
Insulin resistance inH pyloriinfection and its association with oxidative stress
Aslan, M. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i42.6865 · Cited by 50
Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome
Çalan, M., Yılmaz, Ö., Küme, T., Kocabaş, G. Ü., Senses, P. Y., Senses, Y. M., Temür, M., & Çalan, Ö. G. (2016) · Endocrine · doi:10.1007/s12020-016-0875-z · Cited by 50
Intermittent Moderate Energy Restriction Improves Weight Loss Efficiency in Diet-Induced Obese Mice
Seimon, R. V., Shi, Y., Slack, K., Lee, K., Fernando, H. A., Nguyen, A., Zhang, L., Lin, S., Enriquez, R. F., Lau, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145157 · Cited by 51
Hwang, Y., Jeon, W. S., Park, C., & Youn, B. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0319-8 · Cited by 52
Gender difference in type 2 diabetes and the role of body iron stores
Aregbesola, A., Voutilainen, S., Virtanen, J. K., Mursu, J., & Tuomainen, T. (2016) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563216646397 · Cited by 52
Sajuthi, S. P., Sharma, N., Chou, J. W., Palmer, N. D., McWilliams, D. R., Beal, J., Comeau, M. E., Ma, L., Calles-Escandón, J., Demons, J. L., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1680-8 · Cited by 49
Ronsley, R. J., Nguyen, D., Davidson, J., & Panagiotopoulos, C. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506001005 · Cited by 52
Preoperative Beta Cell Function Is Predictive of Diabetes Remission After Bariatric Surgery
Souteiro, P., Belo, S., Neves, J. S., Magalhães, D. M. D. S., Silva, R. B., Oliveira, S. C., Costa, M. M., Saavedra, A., Oliveira, J., Cunha, F. M., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2300-3 · Cited by 50
Cheng, Y., Zhang, K., Chen, Y., Li, Y., Li, Y., Fu, K., & Feng, R. (2016) · Nutrients · doi:10.3390/nu8090527 · Cited by 51
Yang, X., Li, M., Haghiac, M., Catalano, P. M., O’Tierney-Ginn, P., & Mouzon, S. H. (2016) · Diabetologia · doi:10.1007/s00125-016-4073-6 · Cited by 50
Zhou, C., Na, L., Shan, R., Yu, C., Li, Y., Wu, X., & Sun, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163571 · Cited by 50
Li, J., Sapper, T. N., Mah, E., Moller, M. V., Kim, J. B., Chitchumroonchokchai, C., McDonald, J. D., & Bruno, R. S. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.12.007 · Cited by 50
Pomar, C. A., van Nes, R., Sánchez, J., Picó, C., Keijer, J., & Palou, A. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.42 · Cited by 51
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline
Tortelli, R., Lozupone, M., Guerra, V., Barulli, M. R., Imbimbo, B. P., Capozzo, R., Grasso, A. C., Tursi, M., Dio, C. D., Sardone, R., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170153 · Cited by 52
Metabolite profiling of obese individuals before and after a one year weight loss program
Geidenstam, N., Al‐Majdoub, M., Ekman, M., Spégel, P., & Ridderstråle, M. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.124 · Cited by 49
Álvarez, C., Ramírez‐Campillo, R., Ramírez‐Vélez, R., & Izquierdo, M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00479 · Cited by 56
Bioavailable testosterone is independently associated with Fatty Liver Index in postmenopausal women
Klisic, A. N., Kavarić, N., Jovanović, M., Soldatović, I., Barhanovic, N. G., & Kotur‐Stevuljević, J. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.68972 · Cited by 50
Saha, M. R., Dey, P., Sarkar, I., Sarker, D. D., Haldar, B., Chaudhuri, T. K., & Sen, A. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.08.036 · Cited by 51
Min, S. H., Oh, T. J., Baek, S., Lee, D.-H., Kim, K. M., Moon, J. H., Choi, S. H., Park, K. S., Jang, H. C., & Lim, S. K. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.09.006 · Cited by 50
Schwenger, K. J. P., Fischer, S. E., Jackson, T. D., Okrainec, A., & Allard, J. P. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2980-3 · Cited by 51
Wei, Z., Weng, S., Wang, L., & Mao, Z.-J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8084 · Cited by 50
Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States
Selvakumar, P. K. C., Kabbany, M. N., López, R., Rayas, M. S., Lynch, J. L., & Alkhouri, N. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001974 · Cited by 50
Antwi, S. O., Mousa, O. Y. S., & Patel, T. C. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8659 · Cited by 50
Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver disease
Britton, L. J., Bridle, K. R., Reiling, J., Santrampurwala, N., Wockner, L. F., Ching, H. L., Stuart, K. A., Subramaniam, V. N., Jeffrey, G. P., Pierre, T. G. S., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1190 · Cited by 50
Khan, H. A., Sobki, S. H., Ekhzaimy, A. A., Khan, I., & Almusawi, M. A. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2018.05.027 · Cited by 49
Yen, C., Chu, Y.-J., Lee, B., Lin, Y., & Lin, P. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518001241 · Cited by 50
Yılmaz, B., Vellanki, P., Ata, B., & Yıldız, B. O. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.04.024 · Cited by 53
Roy, B., Riley, C. L., & Sinha, R. (2018) · Stress · doi:10.1080/10253890.2018.1490724 · Cited by 53
Lazo-Porras, M., Bernabé‐Ortiz, A., Ruíz-Alejos, A., Smeeth, L. L., Gilman, R. H., Checkley, W., Málaga, G., & Miranda, J. J. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107829 · Cited by 53
Agarwal, S., Fulgoni, V. L. I., & Welland, D. (2019) · Nutrients · doi:10.3390/nu11102513 · Cited by 56
Caselli, C., Turco, S. D., Ragusa, R., Lorenzoni, V., Graaf, M. A. D., Basta, G., Scholte, A. J. H. A., Caterina, R. D., & Neglia, D. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0949-3 · Cited by 50
Amino acids levels in early pregnancy predict subsequent gestational diabetes
Jiang, R., Wu, S., Fang, C., Wang, C., Yang, Y., Liu, C., Hu, J., & Huang, Y. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.13018 · Cited by 51
Association between adherence to the Mediterranean Diet and circulating Vitamin D levels
Zupo, R., Lampignano, L., Lattanzio, A., et al. (2020) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2020.1744533 · Cited by 50
Rayner, C. K., Watson, L. E., Phillips, L. K., Lange, K. M., Bound, M. J., Grivell, J., Wu, T., Jones, K. L., Horowitz, M., Ferrannini, E., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0190 · Cited by 52
Ong, Y. Y., Sadananthan, S. A., Aris, I. M., Tint, M. T., Yuan, W. L., Huang, J. Y., Chan, Y. H., Ng, S., Loy, S. L., Velan, S. S., et al. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa143 · Cited by 55
Lakka, T. A., Lintu, N., Väistö, J., Viitasalo, A., Sallinen, T., Haapala, E. A., Tompuri, T., Soininen, S., Karjalainen, P., Schnurr, T. M., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05250-0 · Cited by 52
Al-Bayyari, N. S., Al-Domi, H. A., Zayed, F., Hailat, R., & Eaton, A. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.09.024 · Cited by 50
Fu, Y., Yin, R., Liu, Z., Niu, Y., Guo, E., Cheng, R., Diao, X., Xue, Y., & Shen, Q. (2020) · Nutrients · doi:10.3390/nu12113452 · Cited by 50
Memelink, R. G., Pasman, W. J., Bongers, A., Tump, A. C., van Ginkel, A., Tromp, W., Wopereis, S., Verlaan, S., den Bosch, J. D. V., & Weijs, P. J. M. (2020) · Nutrients · doi:10.3390/nu13010064 · Cited by 56
Bancks, M. P., Bertoni, A. G., Carnethon, M. R., Chen, H., Cotch, M. F., Gujral, U. P., Herrington, D. M., Kanaya, A. M., Szklo, M., Vaidya, D. M., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa962 · Cited by 49
Cuthbertson, D. J., Koskinen, J. M., Brown, E. E., Magnussen, C. G., Hutri‐Kähönen, N., Sabin, M. A., Tossavainen, P. H., Jokinen, E. V., Laitinen, T. P., Viikari, J. S. A., et al. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1956685 · Cited by 50
Circulating Betatrophin Levels Are Increased in Anorexia and Decreased in Morbidly Obese Women
Barja-Fernández, S., Folgueira, C., Seoane, L. M., Casanueva, F. F., Diéguez, C., Castelao, C., Agüera, Z., Baños, R., Botella, C., de la Torre, R., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1595 · Cited by 50
Coefficient of failure: a methodology for examining longitudinal β‐cell function in Type 2 diabetes
Wallace, T. M., & Matthews, D. R. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00718.x · Cited by 50
Self-citationYeung, D. C. Y., Wang, Y., Xu, A., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn295 · Cited by 50
Periodontitis Deteriorates Metabolic Control in Type 2 Diabetic Goto‐Kakizaki Rats
Pontes, C. D. N., Buschard, K., Flyvbjerg, A., Stoltze, K., & Holmstrup, P. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.050184 · Cited by 50
de Luis, D. A., Aller, R., Izaola, O., Sagrado, M. G., Conde, R., & González, J. M. D. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.07.015 · Cited by 49
Sinitskaya, N., Gourmelen, S., Schuster, C., Lemaître, B. J., Pévet, P., & Challet, É. (2007) · Clinical Science · doi:10.1042/cs20070182 · Cited by 51
Muramatsu, T., Yatsuya, H., Toyoshima, H., Sasaki, S., Li, Y., Otsuka, R., Wada, K., Hotta, Y., Mitsuhashi, H., & Matsushita, K. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.02.014 · Cited by 53
Prevalence and Predictors of Abnormal Liver Enzymes in Young Women with Anorexia Nervosa
Fong, H., DiVasta, A. D., DiFabio, D., et al. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.01.036 · Cited by 50
Iwamoto, N., Ogawa, Y., Kajihara, S., et al. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00633-7 · Cited by 50
Leptin Levels in Diabetic and Nondiabetic Subjects
Tatti, P., Masselli, L., Buonanno, A., Mauro, P. D., & Strollo, F. (2001) · Endocrine · doi:10.1385/endo:15:3:305 · Cited by 50
Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor
Murphy, R., Tura, A., Clark, P. M., Holst, J. J., Mari, A., & Hattersley, A. T. (2008) · Diabetologia · doi:10.1007/s00125-008-1183-9 · Cited by 50
Hayakawa, T., Takamura, T., Abe, T., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2006.08.020 · Cited by 50
Pei, D., Hsieh, C.-H., Hung, Y.-J., Li, J.-C., Lee, C.-H., & Kuo, S.-W. (2006) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2006.02.021 · Cited by 49
Kato, I. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00578-4 · Cited by 50
Botella-Carretero, J. I., Álvarez‐Blasco, F., Sancho, J., & Escobar-Morreale, H. F. (2006) · Thyroid · doi:10.1089/thy.2006.16.397 · Cited by 50
Comparisons of Metabolic Syndrome Definitions in Four Populations of the Asia-Pacific Region
Lee, C., Huxley, R., Woodward, M., Zimmet, P., Shaw, J. E., Cho, N. H., Kim, H. R., Viali, S., Tominaga, M., Vistisen, D., et al. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2007.0024 · Cited by 50
Intestinal permeability in cirrhotic patients with and without ascites
Kalaitzakis, E., Johansson, J., Bjarnason, I., & Bjornsson, E. S. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510024278 · Cited by 50
Egan, B. M., Papademetriou, V., Wofford, M. R., Calhoun, D. A., FERNANDES, J., RIEHLE, J., NESBITT, S., Michelson, E. L., & Julius, S. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.08.008 · Cited by 50
Bitnun, A., Sochett, E. B., Babyn, P., Holowka, S. A., Stephens, D., Read, S., & King, S. (2003) · AIDS · doi:10.1097/00002030-200306130-00006 · Cited by 50
Determinants of Insulin Resistance in Renal Transplant Recipients
Oterdoom, L. H., de Vries, A. P. J., Gansevoort, R. T., van Son, W. J., van der Heide, J. J. H., Ploeg, R. J., de Jong, P. E., Gans, R. O. B., & Bakker, S. J. L. (2007) · Transplantation · doi:10.1097/01.tp.0000245844.27683.48 · Cited by 50
Liou, C., Lin, T., Weng, H., Lee, C.-F., Chen, T., Wei, Y., Chen, S., Chuang, Y., Weng, S., & Wang, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0653 · Cited by 50
Guleria, R. S., Singh, A. B., Nizamutdinova, I. T., Souslova, T., Mohammad, A. A., Kendall, J. A., Baker, K. M., & Pan, J. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.01.017 · Cited by 50
Jeong, H., Kwon, H. J., & Kim, M. K. (2009) · Nutrition Research and Practice · doi:10.4162/nrp.2009.3.1.23 · Cited by 53
Brignardello, E., Runzo, C., Aragno, M., Catalano, M. G., Cassader, M., Perin, P. C., & Boccuzzi, G. (2007) · Diabetes Care · doi:10.2337/dc07-1110 · Cited by 49
Blackburn, P., Lemieux, I., Lamarche, B., Bergeron, J., Perron, P., Tremblay, G., Gaudet, D., & Després, J. (2007) · Diabetes Care · doi:10.2337/dc07-0272 · Cited by 50
Færch, K., Lau, C. J., Tetens, I., Pedersen, O. B., Jørgensen, T., Borch‐Johnsen, K., & Glümer, C. (2005) · Journal of Nutrition · doi:10.1093/jn/135.5.1177 · Cited by 51
Rosmond, R., Chagnon, M., & Bouchard, C. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.371 · Cited by 50
G�ke, B. (2002) · Treatments in Endocrinology · doi:10.2165/00024677-200201050-00005 · Cited by 51
Howard, B. V., Hsia, J. A., Ouyang, P., Voorhees, L. V., Lindsay, J. M., Silverman, A., Alderman, E. L., Tripputi, M., & Waters, D. D. (2004) · Circulation · doi:10.1161/01.cir.0000134955.93951.d5 · Cited by 50
Lawlor, D. A., Ebrahim, S. B. J., & Smith, G. D. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01245.x · Cited by 49
Snehalatha, C., Sivasankari, S., Satyavani, K., Viswanathan, V., & Ramachandran, A. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00239.x · Cited by 50
Madjd, A., Taylor, M. A., Delavari, A., Malekzadeh, R., Macdonald, I. A., & Farshchi, H. R. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.109397 · Cited by 49
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
